Contact CFFC

Sep

Clinical Trial Alerts – September 2020

Cystic Fibrosis Foundation issued the following clinical trial alerts in the month of September.

September 8, 2020

Study to evaluate the effects of CFTR modulators in infants and young children (BEGIN Part A)

Status: Enrolling

Description: This two-part observational study will look at the effects of CFTR modulators on growth in young children with CF. These drugs are intended to help CFTR protein function closer to normal.

Age: 0 Years to 4 Years

Mutation: No Mutation Requirement

Fev1% Predicted: No FEV1 Limit

Number of Visits: 6

Length of Participation: 3 years

ClinicalTrials.gov link: https://clinicaltrials.gov/ct2/show/NCT04509050

Study to evaluate the effects of CFTR modulators in infants and young children (BEGIN Part B)

Status: Enrolling

Description: This two-part observational study will look at the effects of CFTR modulators on growth in young children with CF. These drugs are intended to help CFTR protein function closer to normal.

Age: Less than 6 Years

Mutation: No Mutation Requirement

Fev1% Predicted: No FEV1 Limit

Number of Visits: 6

Length of Participation: 2 years

ClinicalTrials.gov link: https://www.clinicaltrials.gov/ct2/show/NCT04509050


Comments are closed.